RNS Number : 3149X

Societe Generale SA

03 May 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	30/04/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	1,314,780	1.02	4,212	0.00
(2) Derivatives (other than options)	1,134	0.00	586,027	0.45
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,565,310	1.21	590,239	0.46

* Include the holding of shares 249,396 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	100	262.24
Purchase	100	264.05
Purchase	100	260.41
Purchase	73	259.59
Purchase	100	259.61
Purchase	1	259.58
Purchase	14,136	258.86
Purchase	100	259.645
Purchase	1	259.64
Purchase	1	259.64
Purchase	75	259.64
Purchase	77	259.7
Purchase	100	259.7
Purchase	2	259.58
Purchase	1	259.59
Purchase	100	262.1
Purchase	6	259.64
Purchase	50	259.62
Purchase	44	259.64
Purchase	31	259.68
Purchase	8	260.59
Purchase	100	260.53
Purchase	28	258.17
Purchase	100	261.81
Purchase	40	258.59
Purchase	60	258.59
Purchase	100	262.37
Purchase	91	259.63
Purchase	20	261.23
Purchase	20	261.23
Purchase	3	261.23
Purchase	20	261.23
Purchase	37	261.23
Purchase	100	260.93
Purchase	64	262.23
Purchase	16	262.23
Purchase	20	262.23
Purchase	20	257.64
Purchase	80	257.64
Purchase	45	259.83
Purchase	55	259.83
Purchase	4	247.67
Purchase	116	258.86
Purchase	116	258.86
Sale	100	260.69
Sale	6	259.57
Sale	23	259.57
Sale	23	259.57
Sale	43	259.57
Sale	5	259.57
Sale	300	258.86
Sale	100	260.71
Sale	1,642	258.86
Sale	364	258.86
Sale	100	259.9
Sale	100	260.02
Sale	31	259.57
Sale	100	260.71
Sale	64	259.57
Sale	93	260.68
Sale	7	260.68
Sale	100	259.78
Sale	5	259.77
Sale	70	259.77
Sale	25	259.77
Sale	100	258.86
Sale	912	258.86
Total Purchases	16,461
Total Sales	4,313

Derivatives transactions (other than options transactions)

Product name,
e.g. CFD Nature of transaction
(Note 6) Number of relevant securities
(Note 7) Price per unit USD
(Note 5)

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any 
relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 
which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	03/05/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFLREFIVIIL